Search research articles
Contact Us
Filters
Showing results (261-270 of 266) with videos related to
Page
of 27
Sort By:
You have reached the last page of results.
This site can display upto 266 results.
Frontiers in Oncology
|
July 10, 2023
Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment
Pi-Yi Chang, Rheun-Chuan Lee, Po-Chin Liang, et al.
Annals of Hepatology
|
August 7, 2025
Secular trends and survival impact of high proportion of curative treatments for hepatocellular carcinoma in Taiwan, 2011-2019
Kwong-Ming Kee, Chien-Hung Chen, Tsang-Wu Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 6, 2017
Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden
Meredith L Stone, Katherine B Chiappinelli, Huili Li, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 6, 2018
Reply to Haffner et al.: DNA hypomethylation renders tumors more immunogenic
Meredith L Stone, Katherine B Chiappinelli, Huili Li, et al.
Viruses
|
January 21, 2023
Secular Trends of Clinical Characteristics and Survival of Hepatocellular Carcinoma in Taiwan from 2011 to 2019
Kwong-Ming Kee, Chien-Hung Chen, Jui-Ting Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2018
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
Pierce K H Chow, Mihir Gandhi, Say-Beng Tan, et al.
Page
of 27
Search research articles
Search
Showing results (261-270 of 266) with videos related to
Sort By:
Page
of 27
You have reached the last page of results.
This site can display upto 266 results.
Frontiers in Oncology
|
July 10, 2023
Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment
Pi-Yi Chang, Rheun-Chuan Lee, Po-Chin Liang, et al.
Annals of Hepatology
|
August 7, 2025
Secular trends and survival impact of high proportion of curative treatments for hepatocellular carcinoma in Taiwan, 2011-2019
Kwong-Ming Kee, Chien-Hung Chen, Tsang-Wu Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 6, 2017
Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden
Meredith L Stone, Katherine B Chiappinelli, Huili Li, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 6, 2018
Reply to Haffner et al.: DNA hypomethylation renders tumors more immunogenic
Meredith L Stone, Katherine B Chiappinelli, Huili Li, et al.
Viruses
|
January 21, 2023
Secular Trends of Clinical Characteristics and Survival of Hepatocellular Carcinoma in Taiwan from 2011 to 2019
Kwong-Ming Kee, Chien-Hung Chen, Jui-Ting Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2018
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
Pierce K H Chow, Mihir Gandhi, Say-Beng Tan, et al.
Page
of 27